Concord Biotech Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Revised Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Earnings Call with Investor/Analyst (Participants) to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the second quarter and half year ended 30 September, 2024, scheduled on Tuesday, 12th November, 2024 at 2:00 P.M. IST